Athenex, Inc. (ATNX) Social Stream
Featured Post From StockTwits About ATNX
$ATNXboblo9, published August 13, 2021
Oraxol - potential we see a boost in Q4 if ATNX announces that the new study is to be of a shorter duration focused more on safety than on outcome. This would be good news because I expect that the neutropenia will not be an issue with US patients who are given drugs to boost blood counts.
Klisyri - unfortunately no one cares about this drug. Maybe if they unexpectedly announce killer sales by Q4 we will see a boost.
Other pipeline - IMO this is where we have the most potential to see a rise in share price. If ATNX announces positive phase 1 or phase 2 data on any of their products, especially KUR502 which is used to treat leukemia/lymphoma (which is a much bigger market than neuroblastoma for KUR501 or angiosarcoma for Oraxol).
I'm still holding hoping we see some good data. Would like to exit my position completely near 5.0.